KR30031
KR30031 is a verapamil-derived P-glycoprotein inhibitor with comparable efficacy to verapamil but reduced cardiovascular effects. It enhances the bioavailability of co-administered drugs like paclitaxel in anticancer research and is utilized in both in vitro and in vivo studies of multidrug resistance.
Product Specifications
CAS Number
205535-74-6
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Smiles
C (CCN (CCC1=CC (OC) =C (OC) C=C1) C) C2 (C#N) C=3C (CC2) =C (OC) C (OC) =CC3
Molecular Formula
C26H34N2O4
Molecular Weight
438.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1035264-01 0.02 mg (E-Coli)
Recombinant Arabidopsis thaliana Acetyl-CoA carboxylase 2 (ACC2) , partial
Sign In for Pricing
View Details MBS1035264-02 0.1 mg (E-Coli)
Recombinant Arabidopsis thaliana Acetyl-CoA carboxylase 2 (ACC2) , partial
Sign In for Pricing
View Details MBS1035264-03 0.02 mg (Yeast)
Recombinant Arabidopsis thaliana Acetyl-CoA carboxylase 2 (ACC2) , partial
Sign In for Pricing
View Details